Impaired Cardiopulmonary Baroreflex Function and Altered Cardiovascular Responses to Hypovolemia in Patients with Heart Failure with Preserved Ejection Fraction
Jeremy K. Alpenglow,Kanokwan Bunsawat,Michael A. Francisco,Jesse C. Craig,Jarred J. Iacovelli,John J. Ryan,D. Walter Wray
DOI: https://doi.org/10.1152/japplphysiol.00510.2023
2024-01-06
Journal of Applied Physiology
Abstract:Heart failure with preserved ejection fraction (HFpEF) is associated with autonomic imbalance which may be related to baroreflex dysfunction. Thus, we tested the hypothesis that central and peripheral hemodynamic responses to baroreflex activation via lower-body negative pressure (LBNP; -10, -20, -30, -40 mmHg) would be diminished in patients with HFpEF ( n = 10, 71±7 yrs) compared to older, healthy controls (CON, n = 10, 70±5 yrs). Changes in heart rate (HR), mean arterial pressure (MAP, Finapres), forearm blood flow (FBF, ultrasound Doppler), stroke volume (SV, Modelflow), and thoracic impedance (Z) were determined. Lower levels of LBNP (-10 and -20 mmHg) were used to specifically assess the cardiopulmonary baroreflex, while responses across the entire range of LBNP represented an integrated baroreflex response. LBNP significantly increased in HR in CON subjects at -30 and -40 mmHg (+3±4 and +7±5 bpm, P<0.05), but was unchanged in patients with HFpEF across all LBNP levels. LBNP provoked progressive peripheral vasoconstriction, as quantified by changes in forearm vascular conductance (FVC), in both groups. However, a marked (40-60%) attenuation in FVC responses was observed in patients with HFpEF (-6±8, -15±6, -16±5, and -19±7 ml/min/mmHg at -10, -20, -30, and -40 mmHg, respectively) compared to controls (-16±10, -24±8, -27±10, and -31±10 ml/min/mmHg, P<0.05). MAP and SV were unchanged in both groups. Together, these data provide new evidence for impairments in both cardiopulmonary and integrated baroreflex responsiveness in patients with HFpEF, which may be an important aspect of the disease-related decline of autonomic cardiovascular control in this patient group.
physiology,sport sciences